Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

ClinicalTrials.gov ID: NCT05901831

Public ClinicalTrials.gov record NCT05901831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 8:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel-group, Randomized, Prospective, Interventional, Double-blind, Multicenter Global Phase 3 Study to Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Addition to Standard of Care, in Participants With Chronic Kidney Disease and Type 1 Diabetes

Study identification

NCT ID
NCT05901831
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
241 participants

Conditions and interventions

Interventions

  • Finerenone Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 25, 2024
Primary completion
Aug 19, 2025
Completion
Sep 14, 2025
Last update posted
Oct 20, 2025

2024 – 2025

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Southwest Kidney Institute, PLC - Suprise Surprise Arizona 85374
Stanford Endocrinology Clinic Stanford California 94305
Touro University California - Metabolic Research Center Vallejo California 94592
UHealth Diabetes Research Center Miami Florida 33136
AdventHealth Translational Research Institute Orlando Florida 32804
Elixia Central Florida Orlando Florida 32806
Hanson Clinical Research Center, Inc. Port Charlotte Florida 33952
Jedidiah Clinical Research Tampa Florida 33619
Metabolic Research Institute, Inc. West Palm Beach Florida 33401
Grady Memorial Hospital - Endocrinology Atlanta Georgia 30303
Northwestern University | Feinberg School of Medicine - Division of Endocrinology, Metabolism and Molecular Medicine Chicago Illinois 60611
UChicago Medicine Kovler Diabetes Center Chicago Illinois 60637
Preventive Intervention Center - Endocrinology Iowa City Iowa 52202
Wichita Nephrology Group Pa Wichita Kansas 67214
Diabetes & Metabolism Associates Metairie Louisiana 70006
MedStar Health Research Institute Hyattsville Maryland 20782
Joslin Diabetes Center Boston Massachusetts 02215
MU Health Care - University Hospital - Endocrinology Columbia Missouri 65212
Washington University School of Medicine in St. Louis St Louis Missouri 63110-1010
UNC Endocrinology, Diabetes, and Obesity Clinical Research Unit Chapel Hill North Carolina 27514
Physicians East, P.A.- W. H. Smith - Endocrinology Greenville North Carolina 27834
Accellacare - Wilmington Wilmington North Carolina 28401
Cleveland Clinic - Main Campus Cleveland Ohio 44195
OHSU Physicians Pavillion - Endocrinology Portland Oregon 97239
UT Health San Antonio - Medical Arts & Research Center - Endocrinology San Antonio Texas 78229
Consano Clinical Research, LLC. San Antonio Texas 79231
EVMS Strelitz Diabetes Center Norfolk Virginia 23510
Providence Medical Research Center Spokane Valley Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05901831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2025 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05901831 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →